PALO ALTO, Calif.--(BUSINESS WIRE)--StemCells, Inc. (NASDAQ:STEM) announced today that it welcomes and supports the National Neurotechnology Inititative Act, and its goal of fostering new discoveries and accelerating the development of new and safer treatments for brain-related injury or disease. The bill, introduced a few days ago by a bipartisan group of members of both houses of Congress, aims to increase the speed at which scientific discoveries are translated into actual products or treatments that reach the market by improving neuroscience research coordination among various Federal agencies and easing bottlenecks that inhibit the development of treatments for brain-related diseases.
